Virologic failure after 48 weeks of raltegravir-based regimen in low HIV-1 incidence setting
{{output}}
Background: With the advent of next generation integrase strand transfer inhibitors, the rates of virologic failure in treated subjects are expected to decrease. In this study, we analyzed the mutation patterns leading to virolog... ...
